Double-blind trial with increasing doses of salbutamol and terbutaline aerosols in patients with reversible airways obstruction.
D000328:Adult; D000336:Aerosols; D000368:Aged; D000402:Airway Obstruction / Q000188:drug therapy*; D000605:Amino Alcohols / Q000008:administration & dosage* / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D002082:Butylamines / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004983:Ethanolamines / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D012118:Resorcinols / Q000008:administration & dosage / Q000627:therapeutic use; D012119:Respiration / Q000187:drug effects; D012138:Respiratory Therapy; D013147:Spirometry; D013997:Time Factors
D000336:Aerosols; D000605:Amino Alcohols; D001993:Bronchodilator Agents; D002082:Butylamines; D004983:Ethanolamines; D010919:Placebos; D012118:Resorcinols